Tevogen Bio Inc. (TVGN)
NASDAQ: TVGN
· Real-Time Price · USD
0.95
-0.03 (-3.06%)
At close: Aug 15, 2025, 3:59 PM
0.94
-0.51%
After-hours: Aug 15, 2025, 07:49 PM EDT
Tevogen Bio Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Revenue | 396.59K | 396.59K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 298.28K | 396.59K | 198.29K | 198.29K | 98.3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 98.3K | n/a | -198.29K | -198.29K | -98.3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -34.4M | -53.56M | -44.85M | -41.09M | -34.67M | -7.48M | -7.05M | -4.92M | -2.99M | -953.08K | -910.3K | -711.59K | -464.31K | -181.43K | -11.42K | -11.3K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | 2.74M | 4.48M | 4.81M | 4.95M | 2.22M | 484.53K | 156.7K | 15.81K | n/a | n/a |
Pretax Income | -35.36M | -13.73M | -5.11M | 493.73K | -12.03M | -54.05M | -50.6M | -48.71M | -26.32M | 4.41M | 1.78M | 163.56K | -54.73K | -28.75K | -11.41K | -11.3K |
Net Income | -35.36M | -13.73M | -5.11M | -3.13M | -15.65M | -57.67M | -54.23M | -48.71M | -26.32M | 4.41M | 1.78M | 163.56K | -54.73K | -28.75K | -11.41K | -11.3K |
Selling & General & Admin | 21.05M | 22.59M | 16.65M | 15.04M | 11.71M | 3.99M | 3.55M | 2.54M | 1.65M | 953.08K | 910.3K | 711.59K | 464.3K | 181.42K | 11.41K | 11.3K |
Research & Development | 13.42M | 31.03M | 28.2M | 26.05M | 22.96M | 3.5M | 5.25M | 5.93M | 4.9M | 3.56M | 1.8M | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 34.4M | 53.56M | 44.85M | 41.09M | 34.67M | 7.48M | 7.05M | 4.92M | 2.99M | 953.08K | 910.3K | 711.59K | 464.3K | 181.42K | 11.41K | 11.3K |
Interest Expense | 3.69K | 184.04K | 168.25K | 455.73K | 755.62K | 888.83K | 888.83K | 588.88K | 289K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 60K | 60K | -285.89K | -285.89K | -285.89K | -285.89K | -970.95K | -2.97M | -2.97M | -2.97M | -2M | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 24.25M | 53.76M | 44.85M | 41.09M | 34.67M | 7.48M | 7.05M | 4.92M | 2.99M | 953.08K | 910.3K | 711.59K | 464.3K | 181.42K | 11.41K | 11.3K |
Income Tax Expense | 60K | 60K | -44.09K | -83.83K | -83.83K | -83.83K | -39.73K | -2.1K | -2.1K | -2.1K | -2.1K | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 161.41M | 177.99M | 170.17M | 154.17M | 137.33M | 161.77M | 158.11M | 139.06M | 120M | 47.93M | 47.93M | 47.93M | 47.93M | 47.93M | 46.48M | 46.48M |
Shares Outstanding (Diluted) | 161.41M | 177.99M | 170.17M | 154.17M | 142.39M | 161.77M | 158.11M | 139.06M | 120M | 47.93M | 47.93M | 47.93M | 47.93M | 47.93M | 46.48M | 46.48M |
EPS (Basic) | 0.20 | 0.35 | 0.00 | 0.01 | -0.11 | -0.45 | -0.39 | -0.33 | -0.17 | 0.09 | 0.04 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
EPS (Diluted) | 0.20 | 0.01 | -0.34 | -0.33 | -0.45 | -0.45 | -0.39 | -0.33 | -0.17 | 0.09 | 0.04 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
EBITDA | -33.93M | -12.06M | -3.31M | 2.07M | 8.52M | -33.37M | -30.18M | -28.29M | -25.94M | 4.41M | 1.78M | 163.56K | -54.73K | -28.75K | -11.41K | -11.3K |
EBIT | -23.96M | -12.54M | -3.62M | 1.97M | 8.38M | -33.5M | -30.32M | -28.42M | -26.03M | 4.41M | 1.78M | 163.56K | -54.73K | -28.75K | -11.41K | -11.3K |
Depreciation & Amortization | 322.48K | 420.78K | 361.33K | 182.13K | 170.4K | 163.3K | 174.88K | 137.24K | 148.98K | 57.77K | 2.1K | n/a | n/a | n/a | n/a | n/a |